Collaboration, Licensing and Other Arrangements (Tables)

6 Months Ended

Jun. 30, 2021

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Schedule of Revenue from Collaboration and Services

Revenue from collaborations and services for the three and six months ended June 30, 2021 and 2020 are as follows (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
UT License Agreement	$	12,163	$	7,978	$	21,163	$	15,956
Vertice Pharma Co-Promotion Agreement		856		—		1,147		—
Receptor CLA		165		63		175		125
Cipla License and Distribution Agreement		37		35		73		72
Other		83		—		83		—
UT Research Agreement		—		53		—		211
Total revenue from collaborations and services	$	13,304	$	8,129	$	22,641	$	16,364